Developmental stage-dependent impact of midazolam on calbindin, calretinin and parvalbumin expression in the immature rat medial prefrontal cortex during the brain growth spurt

International Journal of Developmental Neuroscience

Volumn 45, Issue , 2015, Pages 19-28

  Osterop, Samira F ^a,b   Virtanen, Mari A ^b   Loepke, Johanna R ^c   Joseph, Bernadin ^c   Loepke, Andreas W ^c,d   Vutskits, Laszlo ^a,b,e  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^d UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF GENEVA   (Switzerland)

Author keywords

Anesthesia; Brain; Development; GABA; Plasticity

Indexed keywords

CALBINDIN; CALRETININ; CASPASE 3; MIDAZOLAM; PARVALBUMIN; 4 AMINOBUTYRIC ACID RECEPTOR; HYPNOTIC SEDATIVE AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BRAIN DEVELOPMENT; BRAIN GROWTH; BRAIN TISSUE; CELL POPULATION; CONTROLLED STUDY; DEVELOPMENTAL STAGE; DRUG EXPOSURE; IMMUNOHISTOCHEMISTRY; INTERNEURON; MEDIAL PREFRONTAL CORTEX; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; STEREOLOGY; WISTAR RAT; AGING; ANIMAL; DOSE RESPONSE; DRUG EFFECTS; GENE EXPRESSION REGULATION; METABOLISM; PHYSIOLOGY; PREFRONTAL CORTEX;

AGING; ANIMALS; APOPTOSIS; CALBINDIN 2; CALBINDINS; DOSE-RESPONSE RELATIONSHIP, DRUG; GABAERGIC NEURONS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HYPNOTICS AND SEDATIVES; MIDAZOLAM; PARVALBUMINS; PREFRONTAL CORTEX; RATS; RATS, WISTAR;

EID: 84946158018     PISSN: 07365748     EISSN: 1873474X     Source Type: Journal    
DOI: 10.1016/j.ijdevneu.2015.04.002     Document Type: Article

References (35)

1. Anand K.J., Soriano S.G. Anesthetic agents and the immature brain: are these toxic or therapeutic?. Anesthesiology 2004, 101:527-530.
2. Ascoli G.A., Alonso-Nanclares L., Anderson S.A., Barrionuevo G., Benavides-Piccione R., Burkhalter A., Buzsaki G., Cauli B., Defelipe J., Fairen A., Feldmeyer D., Fishell G., Fregnac Y., Freund T.F., Gardner D., Gardner E.P., Goldberg J.H., Helmstaedter M., Hestrin S., Karube F., Kisvarday Z.F., Lambolez B., Lewis D.A., Marin O., Markram H., Munoz A., Packer A., Petersen C.C., Rockland K.S., Rossier J., Rudy B., Somogyi P., Staiger J.F., Tamas G., Thomson A.M., Toledo-Rodriguez M., Wang Y., West D.C., Yuste R. Petilla terminology: nomenclature of features of GABAergic interneurons of the cerebral cortex. Nat. Rev. Neurosci. 2008, 9:557-568.
3. Baroncelli L., Braschi C., Spolidoro M., Begenisic T., Maffei L., Sale A. Brain plasticity and disease: a matter of inhibition. Neural Plast. 2011, 2011:286073.
4. Brambrink A.M., Evers A.S., Avidan M.S., Farber N.B., Smith D.J., Zhang X., Dissen G.A., Creeley C.E., Olney J.W. Isoflurane-induced neuroapoptosis in the neonatal rhesus macaque brain. Anesthesiology 2010, 112:834-841.
5. Briner A., Nikonenko I., De Roo M., Dayer A., Muller D., Vutskits L. Developmental stage-dependent persistent impact of propofol anesthesia on dendritic spines in the rat medial prefrontal cortex. Anesthesiology 2011, 115:282-293.
6. Clancy B., Finlay B.L., Darlington R.B., Anand K.J. Extrapolating brain development from experimental species to humans. Neurotoxicology 2007, 28:931-937.
7. De Roo M., Klauser P., Briner A., Nikonenko I., Mendez P., Dayer A., Kiss J.Z., Muller D., Vutskits L. Anesthetics rapidly promote synaptogenesis during a critical period of brain development. PLoS One 2009, 4:e7043.
8. Donato F., Rompani S.B., Caroni P. Parvalbumin-expressing basket-cell network plasticity induced by experience regulates adult learning. Nature 2013, 504:272-276.
9. Druga R. Neocortical inhibitory system. Folia Biol. (Praha) 2009, 55:201-217.
10. De Felipe J., Marco P., Fairen A., Jones E.G. Inhibitory synaptogenesis in mouse somatosensory cortex. Cereb. Cortex 1997, 17:619-634.
11. del Rio J.A., de Lecea L., Ferrer I., Soriano E. The development of parvalbumin-immunoreactivity in the neocortex of the mouse. Brain Res. Dev. Brain Res. 1994, 81:247-259.
12. Eichler S.A., Meier J.C. E-I balance and human diseases - from molecules to networking. Front. Mol. Neurosci. 2008, 1:2.
13. Gogolla N., Leblanc J.J., Quast K.B., Sudhof T.C., Fagiolini M., Hensch T.K. Common circuit defect of excitatory-inhibitory balance in mouse models of autism. J. Neurodev. Disord. 2009, 1:172-181.
14. Grateron L., Cebada-Sanchez S., Marcos P., Mohedano-Moriano A., Insausti A.M., Munoz M., Arroyo-Jimenez M.M., Martinez-Marcos A., Artacho-Perula E., Blaizot X., Insausti R. Postnatal development of calcium-binding proteins immunoreactivity (parvalbumin, calbindin, calretinin) in the human entorhinal cortex. J. Chem. Neuroanat. 2003, 26:311-316.
15. Hensch T.K. Critical period regulation. Ann. Rev. Neurosci. 2004, 27:549-579.
16. Hensch T.K. Bistable parvalbumin circuits pivotal for brain plasticity. Cell 2014, 156:17-19.
17. Helmeke C., Ovtscharoff W.J., Poeggel G., Braun K. Imbalance of immunohistochemically characterized interneuron populations in the adolescent and adult rodent medial prefrontal cortex after repeated exposure to neonatal separation stress. Neuroscience 2008, 152:18-28.
18. Hof P.R., Glezer I.I., Conde F., Flagg R.A., Rubin M.B., Nimchinsky E.A., Vogt Weisenhorn D.M. Cellular distribution of the calcium-binding proteins parvalbumin, calbindin, and calretinin in the neocortex of mammals: phylogenetic and developmental patterns. J. Chem. Neuroanat. 1999, 16:77-116.
19. Hogan D., Roffwarg H.P., Shaffery J.P. The effects of 1 week of REM sleep deprivation on parvalbumin and calbindin immunoreactive neurons in central visual pathways of kittens. J. Sleep Res. 2001, 10:285-296.
20. Holland F.H., Ganguly P., Potter D.N., Chartoff E.H., Brenhouse H.C. Early life stress disrupts social behavior and prefrontal cortex parvalbumin interneurons at an earlier time-point in females than in males. Neurosci. Lett. 2014, 566:131-136.
21. Istaphanous G.K., Ward C.G., Nan X., Hughes E.A., McCann J.C., McAuliffe J.J., Danzer S.C., Loepke A.W. Characterization and quantification of isoflurane-induced developmental apoptotic cell death in mouse cerebral cortex. Anesth. Analg. 2013, 116:845-854.
22. Jevtovic-Todorovic V., Absalom A.R., Blomgren K., Brambrink A., Crosby G., Culley D.J., Fiskum G., Giffard R.G., Herold K.F., Loepke A.W., Ma D., Orser B.A., Planel E., Slikker W.J., Soriano S.G., Stratmann G., Vutskits L., Xie Z., Hemmings H.C.J. Anaesthetic neurotoxicity and neuroplasticity: an expert group report and statement based on the BJA Salzburg Seminar. Br. J. Anaesth. 2013, 111:143-151.
23. Kaila K., Price T.J., Payne J.A., Puskarjov M., Voipio J. Cation-chloride cotransporters in neuronal development, plasticity and disease. Nat. Rev. Neurosci. 2014, 15:637-654.
24. Kubota Y., Hattori R., Yui Y. Three distinct subpopulations of GABAergic neurons in rat frontal agranular cortex. Brain Res. 1994, 649:159-173.
25. Le Magueresse C., Monyer H. GABAergic interneurons shape the functional maturation of the cortex. Neuron 2013, 77:388-405.
26. Lee B.H., Chan J.T., Kraeva E., Peterson K., Sall J.W. Isoflurane exposure in newborn rats induces long-term cognitive dysfunction in males but not females. Neuropharmacology 2014, 83:9-17.
27. Lei S.Y., Hache M., Loepke A.W. Clinical research into anesthetic neurotoxicity: does anesthesia cause neurological abnormalities in humans?. J. Neurosurg. Anesthesiol. 2014, 26:349-357.
28. Lin E.P., Soriano S.G., Loepke A.W. Anesthetic neurotoxicity. Anesthesiol. Clin. 2014, 32:133-155.
29. Markram H., Toledo-Rodriguez M., Wang Y., Gupta A., Silberberg G., Wu C. Interneurons of the neocortical inhibitory system. Nat. Rev. Neurosci. 2004, 5:793-807.
30. Rudolph U., Antkowiak B. Molecular and neuronal substrates for general anaesthetics. Nat. Rev. Neurosci. 2004, 5:709-720.
31. Takesian A.E., Hensch T.K. Balancing plasticity/stability across brain development. Prog. Brain Res. 2013, 207:3-34.
32. Vutskits L., Davis P.J., Hansen T.G. Anesthetics and the developing brain: time for a change in practice? A pro/con debate. Paediatr. Anaesth. 2012, 22:973-980.
33. Vutskits L. General anesthesia: a gateway to modulate synapse formation and neural plasticity?. Anesth. Analg. 2012.
34. Yizhar O., Fenno L.E., Prigge M., Schneider F., Davidson J., O'Shea D.J., Sohal V.S., Goshen I., Finkelstein J., Paz J.T., Stehfest K., Fudim R., Ramakrishnan C., Huguenard J.R., Hegemann P., Deisseroth K. Neocortical excitation/inhibition balance in information processing and social dysfunction. Nature 2011, 477:171-178.
35. Young C., Jevtovic-Todorovic V., Qin Y.Q., Tenkova T., Wang H., Labruyere J., Olney J.W. Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. Br. J. Pharmacol. 2005, 146:189-197.